Viewing Study NCT01645969


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2025-12-29 @ 7:08 AM
Study NCT ID: NCT01645969
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2012-07-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Follow-Up Study of Patients With HBeAg Positive Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML22265
Sponsor: Hoffmann-La Roche
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ML25647
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators